Global Health Pulse: From Nipah to Weight-Loss Pills
The World Health Organization reports a Nipah virus-related death in Bangladesh. President Trump's new drug website offers limited discounts, while New York legalizes medical aid in dying. South Carolina faces a significant measles outbreak. The FDA targets Hims & Hers' weight-loss drug. South Africa starts local foot-and-mouth vaccines.
The World Health Organization (WHO) announced a fatality from the Nipah virus in Bangladesh, marking ongoing health challenges. This case follows similar incidents in India, intensifying precautions across Asia's airports.
President Trump launched TrumpRx.gov to address drug prices, focusing primarily on GLP-1 weight-loss medications. However, experts note its limited impact on overall prescription costs.
Amid rising measles cases, South Carolina reports 920 infections. The outbreak traces back to October, sparking public health warnings and highlighting vaccination gaps.
(With inputs from agencies.)
- READ MORE ON:
- Nipah
- TrumpRx
- weight-loss
- measles
- outbreak
- South Carolina
- FDA
- Hims
- foot-and-mouth
- vaccine
ALSO READ
China Grapples with Foot-and-Mouth Disease Outbreak
Mass Food Poisoning Outbreak in Gujarat's Bhavnagar District
Race to Slim Down: FDA Greenlights Lilly's Weight-Loss Pill 'Foundayo'
FDA Delays: Nicotine Pouch Authorisation Hinges on Youth Risk Concerns
FDA's Cautious Stance Puts Brakes on Nicotine Pouch Approval
Google News